{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-105537","form_type":"8-K","ticker":"TCMD","cik":"0001027838","company_name":"TACTILE SYSTEMS TECHNOLOGY INC","filed_at":"2025-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.585245+00:00","generated_at":"2026-05-17T00:48:44.045497+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tactile Medical Q3 net income $8.2M, revenue up 17%; raises FY guidance and authorizes $25M buyback","bullets":["Q3 revenue $85.8M (+17% YoY), net income $8.2M ($0.36 diluted EPS) vs $5.2M ($0.21) in Q3 2024.","Adjusted EBITDA $14.4M vs $10.7M YoY; gross margin 76% vs 75%.","Paid off $24M term loan, refinanced revolver to $40M; cash $66M.","Authorized $25M share buyback program through Nov 2027.","FY 2025 guidance raised: revenue $317-321M (prior $310-315M), adj. EBITDA $38-39.5M (prior $33-35M)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-105537","json":"https://secwatch.observer/filing/0001104659-25-105537.json","markdown":"https://secwatch.observer/filing/0001104659-25-105537.md","text":"https://secwatch.observer/filing/0001104659-25-105537.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1027838/000110465925105537/0001104659-25-105537-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1027838/000110465925105537/tcmd-20251103x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:48:44.045497+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}